NanoString | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19 results for “NanoString”

Trials

Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)

138 participants · First posted Dec 11, 2018

Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial

200 participants · First posted Jun 4, 2020

A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

200 participants · First posted Mar 23, 2015

Drugs

NanoSTING-001

Organizations

Nanostring Technologies, Inc.

United States

News

Leukemia Stem Cell Test Shows Superior Prediction of AML Relapse After Transplant

B7-H3 Protein May Predict Response to Nivolumab and Relatlimab in Resectable Melanoma

Spatial Proteomics Market Poised to Reach USD 29.97 Billion by 2034, Driven by Precision Oncology and High-Plex Imaging

Page 1 of 2